These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30805885)
1. Quantitative Imaging of Morphometric and Metabolic Signatures Reveals Heterogeneity in Drug Response of Three-Dimensional Mammary Tumor Spheroids. Ramanujan VK Mol Imaging Biol; 2019 Jun; 21(3):436-446. PubMed ID: 30805885 [TBL] [Abstract][Full Text] [Related]
2. Characterization of multicellular breast tumor spheroids using image data-driven biophysical mathematical modeling. Bowers HJ; Fannin EE; Thomas A; Weis JA Sci Rep; 2020 Jul; 10(1):11583. PubMed ID: 32665565 [TBL] [Abstract][Full Text] [Related]
3. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures. Varesano S; Zocchi MR; Poggi A Front Immunol; 2018; 9():998. PubMed ID: 29867975 [TBL] [Abstract][Full Text] [Related]
4. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer. Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188 [TBL] [Abstract][Full Text] [Related]
5. Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer. Alberini JL; Boisgard R; Guillermet S; Siquier K; Jego B; Thézé B; Urien S; Rezaï K; Menet E; Maroy R; Dollé F; Kühnast B; Tavitian B Mol Imaging Biol; 2016 Aug; 18(4):617-26. PubMed ID: 26630973 [TBL] [Abstract][Full Text] [Related]
6. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry. Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923 [TBL] [Abstract][Full Text] [Related]
7. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device. LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110 [TBL] [Abstract][Full Text] [Related]
8. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics. Thakuri PS; Gupta M; Plaster M; Tavana H Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703 [TBL] [Abstract][Full Text] [Related]
10. Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids. Halfter K; Hoffmann O; Ditsch N; Ahne M; Arnold F; Paepke S; Grab D; Bauerfeind I; Mayer B J Transl Med; 2016 May; 14(1):112. PubMed ID: 27142386 [TBL] [Abstract][Full Text] [Related]
11. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids. Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224 [TBL] [Abstract][Full Text] [Related]
12. An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments. Murali VS; Chang BJ; Fiolka R; Danuser G; Cobanoglu MC; Welf ES BMC Cancer; 2019 May; 19(1):502. PubMed ID: 31138163 [TBL] [Abstract][Full Text] [Related]
15. The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures. Narayan RS; Fedrigo CA; Brands E; Dik R; Stalpers LJ; Baumert BG; Slotman BJ; Westerman BA; Peters GJ; Sminia P BMC Cancer; 2017 Mar; 17(1):204. PubMed ID: 28320338 [TBL] [Abstract][Full Text] [Related]
16. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702 [TBL] [Abstract][Full Text] [Related]
17. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors. Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606 [TBL] [Abstract][Full Text] [Related]
18. 3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition. Kelly CJ; Hussien K; Muschel RJ Nucl Med Biol; 2012 Oct; 39(7):986-92. PubMed ID: 22682985 [TBL] [Abstract][Full Text] [Related]
19. Environmental control of mammary carcinoma cell expansion by acidification and spheroid formation in vitro. Ralph ACL; Valadão IC; Cardoso EC; Martins VR; Oliveira LMS; Bevilacqua EMAF; Geraldo MV; Jaeger RG; Goldberg GS; Freitas VM Sci Rep; 2020 Dec; 10(1):21959. PubMed ID: 33319820 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the physical properties of tumor-derived spheroids reveals critical insights for pre-clinical studies. Guillaume L; Rigal L; Fehrenbach J; Severac C; Ducommun B; Lobjois V Sci Rep; 2019 Apr; 9(1):6597. PubMed ID: 31036886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]